SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-074377
Filing Date
2014-10-28
Accepted
2014-10-28 16:05:24
Documents
18
Period of Report
2014-10-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23067_28k.htm 8-K 23900
2 EX-99.1 a14-23067_2ex99d1.htm EX-99.1 27099
3 GRAPHIC g230672mmi001.gif GRAPHIC 32796
4 GRAPHIC g230672mmi002.gif GRAPHIC 66217
5 GRAPHIC g230672mmi003.jpg GRAPHIC 30997
6 GRAPHIC g230672mmi004.gif GRAPHIC 64233
7 GRAPHIC g230672mmi005.gif GRAPHIC 79374
8 GRAPHIC g230672mmi006.gif GRAPHIC 75039
9 GRAPHIC g230672mmi007.gif GRAPHIC 55615
10 GRAPHIC g230672mmi008.gif GRAPHIC 52280
11 GRAPHIC g230672mmi009.gif GRAPHIC 82154
12 GRAPHIC g230672mmi010.gif GRAPHIC 55112
13 GRAPHIC g230672mmi011.jpg GRAPHIC 53960
14 GRAPHIC g230672mmi012.gif GRAPHIC 55106
15 GRAPHIC g230672mmi013.gif GRAPHIC 56182
16 GRAPHIC g230672mmi014.jpg GRAPHIC 58994
17 GRAPHIC g230672mmi015.gif GRAPHIC 31467
18 GRAPHIC g230672mmi016.gif GRAPHIC 20171
  Complete submission text file 0001104659-14-074377.txt   1252799
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 141177174
SIC: 2834 Pharmaceutical Preparations